Pyelonephritis Symptoms and Treatment
Pyelonephritis typically presents with fever (>38°C), chills, flank pain, nausea, vomiting, and tenderness at the costovertebral angle, with or without symptoms of lower urinary tract infection such as dysuria, frequency, and urgency. 1
Clinical Presentation
Key Symptoms
- Systemic symptoms:
- High fever (>38°C)
- Chills
- Malaise
- Vomiting
- Localized symptoms:
- Flank pain
- Costovertebral angle tenderness
- Abdominal pain
- Lower urinary tract symptoms (dysuria, frequency, urgency) may be present but are not required for diagnosis 1
Special Populations
- Children: Presentation may be nonspecific, especially in neonates and young infants, with symptoms similar to sepsis 1
- Elderly and diabetic patients: May present with atypical symptoms; up to 50% of diabetic patients may not have typical flank tenderness 1
- Pregnant women: Require special attention due to increased risk of complications 1
Diagnosis
Laboratory Testing
- Urinalysis: Assessment of white and red blood cells and nitrite is recommended for routine diagnosis 1
- Leukocyte esterase and nitrite tests combined have 75-84% sensitivity and 82-98% specificity for UTI 2
- Urine culture and antimicrobial susceptibility testing: Should be performed in all cases of pyelonephritis before starting antibiotics 1
- Positive in approximately 90% of patients with acute pyelonephritis 2
- Blood cultures: Reserve for patients with uncertain diagnosis, immunocompromised status, or suspected hematogenous infections 2
Imaging
- Initial imaging: Not indicated for uncomplicated pyelonephritis in the first 72 hours 1
- Ultrasound: Recommended to rule out urinary tract obstruction or renal stone disease in patients with:
- History of urolithiasis
- Renal function disturbances
- High urine pH 1
- Additional imaging: Consider contrast-enhanced CT scan or excretory urography if:
- Pregnant women: Use ultrasound or MRI to avoid radiation risk to the fetus 1
Treatment
Outpatient Treatment (Mild Uncomplicated Pyelonephritis)
- Oral antibiotics:
- Fluoroquinolones: First choice if local resistance rates <10%
- Ciprofloxacin: 500-750 mg twice daily for 7 days
- Levofloxacin: 750 mg once daily for 5 days 1
- Alternatives:
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 14 days
- Cefpodoxime: 200 mg twice daily for 10 days
- Ceftibuten: 400 mg once daily for 10 days 1
- Fluoroquinolones: First choice if local resistance rates <10%
Inpatient Treatment (Severe or Complicated Pyelonephritis)
Indications for hospitalization:
Initial IV antibiotics:
- Fluoroquinolones:
- Ciprofloxacin: 400 mg twice daily
- Levofloxacin: 750 mg once daily
- Cephalosporins:
- Ceftriaxone: 1-2 g once daily
- Cefotaxime: 2 g three times daily
- Cefepime: 1-2 g twice daily
- Other options:
- Piperacillin/tazobactam: 2.5-4.5 g three times daily
- Aminoglycosides (gentamicin: 5 mg/kg once daily or amikacin: 15 mg/kg once daily) with or without ampicillin 1
- Fluoroquinolones:
Carbapenems and novel broad-spectrum antimicrobials: Reserve for patients with multidrug-resistant organisms based on culture results 1
Duration of Treatment
- Standard duration: 7-14 days 2
- Short outpatient courses may be equivalent to longer therapy for clinical and microbiological success but may have higher recurrence rates within 4-6 weeks 1
Follow-up
- Repeat urine culture 1-2 weeks after completion of antibiotic therapy 2
- If symptoms persist or recur within 4 weeks, consider subclinical "silent" pyelonephritis requiring a 14-day course of antibiotics 4
- If symptoms and/or bacteriuria recur with the same organism, consider a prolonged 6-week course of antibiotics 4
Complications and Special Considerations
Potential Complications
- Renal scarring (occurs in approximately 15% of children after first episode) 1
- Renal abscess
- Emphysematous pyelonephritis (particularly in diabetic patients) 5
- Sepsis
- Chronic renal failure (long-term risk is now considered low) 1
High-Risk Populations
- Diabetic patients: More vulnerable to complications including renal abscesses and emphysematous pyelonephritis 1
- Pregnant women: Require screening for bacteriuria and prompt treatment to prevent complications 6
- Children: High incidence of urinary anomalies in neonates with UTI 1
- Immunocompromised patients: May require more aggressive treatment and monitoring 1
Treatment Failure
- Consider resistant organisms, underlying anatomic/functional abnormalities, or immunosuppressed states 2
- Repeat blood and urine cultures
- Consider imaging studies
- May require change in antibiotics or surgical intervention 2
Prevention of Recurrent UTIs
- Counseling regarding avoidance of risk factors
- Non-antimicrobial measures (adequate hydration, voiding after intercourse)
- Consider antimicrobial prophylaxis for recurrent infections 1